Healthpeak Properties Inc Stock Price, News & Analysis

Healthpeak Properties (NYSE:DOC) announced that its Board declared a monthly common stock cash dividend of $0.10167 per share for each month of the fourth quarter of 2025. The dividend equals an annualized amount of $1.22 per share.

The declaration sets three record/payment date pairs: record dates of Oct 17, Nov 14, Dec 19, 2025 with corresponding payment dates of Oct 30, Nov 26, Dec 30, 2025, each paying $0.10167 per common share.

Healthpeak Properties (NYSE: DOC), a healthcare real estate company, has scheduled its Q3 2025 earnings release for Thursday, October 23, 2025, after market close. The company will host a conference call and webcast on Friday, October 24, 2025, at 10:00 a.m. Eastern Time to discuss financial results.

Investors can access the conference call through Healthpeak's website or via telephone at (800) 715-9871. A webcast replay will be available on the company's website through October 23, 2026, and a telephonic replay can be accessed through October 31, 2025.

Healthpeak Properties (NYSE: DOC) has released its 14th annual Corporate Impact Report for 2024, showcasing significant achievements in sustainability and corporate governance following its March 2024 merger with Physicians Realty Trust. The company has exceeded two 10-year sustainability targets ahead of schedule, achieving an 11.5% reduction in water consumption and 12.1% increase in recycling since 2020.

Key environmental achievements include an 8.2% reduction in greenhouse gas emissions and 1.8% reduction in energy use in 2024. The company secured 590,000 square feet of new LEED certifications and was named a 2024 ENERGY STAR Partner of the Year for Sustained Excellence. Healthpeak also launched the IDEA Council to enhance workplace culture and strengthened its governance practices.

Healthpeak Properties (NYSE:DOC) has announced key leadership changes to strengthen its life science real estate division. Denis Sullivan joins as Managing Director of Lab Investments & San Diego Market Lead, bringing over two decades of life science real estate expertise, including 14 years at BioMed Realty as CIO and CFO. Additionally, Mike Dorris has been promoted to Head of West Coast Development & Construction.

Sullivan will report to Adam Mabry (CIO) and Scott Bohn (CDO), focusing on portfolio-wide Lab investment strategy and San Diego market operations. Dorris will expand the company's specialized lab design and construction capabilities while strengthening development initiatives. These strategic appointments aim to capitalize on market recovery opportunities and enhance Healthpeak's position in the life science sector.

Healthpeak Properties (NYSE: DOC), through its operating company Healthpeak OP, LLC, has priced a $500 million offering of senior unsecured notes due 2033 with a 4.750% interest rate. The notes are priced at 99.178% of principal amount, with estimated net proceeds of $492.8 million after underwriting discount.

The notes will be fully guaranteed by Healthpeak, DOC DR Holdco, LLC and DOC DR, LLC. The company plans to use the proceeds to repay commercial paper borrowings and for general corporate purposes, including potential debt repayment, acquisitions, development activities, and capital expenditures. The offering is expected to close on August 14, 2025.

Healthpeak Properties (NYSE:DOC) reported its Q2 2025 financial results with net income of $0.05 per share, Nareit FFO of $0.43 per share, and FFO as Adjusted of $0.46 per share. The company demonstrated strong operational performance with Total Merger-Combined Same-Store Cash NOI growth of 3.5%.

Key highlights include 1.5 million square feet of new and renewal lease executions, with strong retention rates of 85% for outpatient medical and 87% for lab spaces. The company entered into two new development agreements worth $148 million with Northside Hospital in Atlanta and declared a quarterly dividend of $0.305 per share.

Healthpeak maintained solid financial health with Net Debt to Adjusted EBITDAre of 5.2x and approximately $2.3 billion in available liquidity. The company reaffirmed its 2025 FFO as Adjusted guidance of $1.81-$1.87 per share while updating its diluted earnings guidance to $0.25-$0.31 per share.

Healthpeak Properties (NYSE: DOC), a healthcare real estate company, has declared its monthly cash dividends for Q3 2025. The company will distribute $0.10167 per share monthly, totaling a quarterly dividend of $0.305 per share and an annualized dividend of $1.22 per share.

The dividends will be paid on July 31, August 29, and September 30, 2025, to stockholders of record as of July 18, August 18, and September 19, 2025, respectively.

Healthpeak Properties (NYSE: DOC), a healthcare real estate company, has scheduled its second quarter 2025 earnings release for Thursday, July 24, 2025, after market close. The company will host a conference call and webcast to discuss the results on Friday, July 25, 2025, at 8:00 a.m. Mountain Time (10:00 a.m. Eastern Time).

Participants can access the conference through Healthpeak's website, webcast link, or via telephone. The webcast recording will be available on the company's website through July 24, 2026, and a phone replay will be accessible until August 1, 2025.

Healthpeak Properties (NYSE: DOC) reported strong Q1 2025 results with net income of $0.06 per share and Nareit FFO of $0.45 per share. The company achieved 7.0% Total Same-Store Portfolio Cash NOI growth, with notable performance across segments: Outpatient Medical (5.0%), Lab (7.7%), and CCRC (15.9%).

Key operational highlights include 1.2 million square feet of new and renewal lease executions, with strong retention rates of 86% in Outpatient Medical and 88% in Lab spaces. The company declared a monthly dividend of $0.10167 per share for Q2 2025, representing an annualized dividend of $1.22 per share.

Financial developments include a $500 million senior notes offering at 5.375%, maintaining a healthy Net Debt to Adjusted EBITDAre of 5.2x. The company has repurchased 5.1 million shares at $18.50 average price and maintains $2.8 billion in available liquidity. 2025 guidance remains unchanged with diluted FFO per share projected at $1.81-$1.87.